| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 17 insiders with recent SEC Form 4 filings, including 1 buy and 14 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.83M | $87.90M | - | |
| Dir | 1.55M | $74.81M | - | |
| Dir | 1.19M | $57.27M | - | |
| CFO | 1.08M | $51.86M | - | |
| VP | 733.1K | $35.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Wyszomierski Jack L | Director | Sale+OE | 99,574 | $44.01 | $4,382,251.74 | -26.2% | - | - | |
| Nov 25, 2025 | Johnson David Edward83 | Director | Buy | 27,532 | $43.12 | $1,187,234.90 | +1.8% | +2.0% | - | |
| Nov 21, 2025 | Haley Patrick J.57 | EVP, Commercial | Sell | 72,230 | $42.18 | $3,046,928.17 | -8.5% | +3.9% | - | |
| Nov 12, 2025 | Papadopoulos Stelios56 | Director | Sell | 100,000 | $43.55 | $4,355,000.00 | -7.8% | -1.4% | - | |
| Nov 11, 2025 | Aftab Dana | EVP, Research And Development | Sell | 48,383 | $42.50 | $2,056,277.50 | -6.8% | +2.3% | - | |
| Nov 11, 2025 | Beckerle Mary C50 | Director | Sale+OE | 24,622 | $41.93 | $1,032,413.72 | -28.6% | +2.3% | - | |
| Jun 3, 2025 | Wyszomierski Jack L | Director | Sell | 7,535 | $43.09 | $324,683.15 | -2.1% | -12.9% | - | |
| Jun 2, 2025 | Eckhardt Sue Gail | Director | Sell | 18,838 | $42.74 | $805,139.84 | -30.6% | -13.3% | - | |
| May 21, 2025 | Heyman Tomas J. | Director | Sell | 4,544 | $44.29 | $201,253.76 | -12.3% | -14.2% | - | |
| May 20, 2025 | Haley Patrick J.57 | EVP, Commercial | Sell | 34,387 | $44.06 | $1,515,091.22 | -7.7% | -14.9% | - |